ACS Publications. Most Trusted. Most Cited. Most Read
My Activity

Influence of Equatorial and Axial Carboxylato Ligands on the Kinetic Inertness of Platinum(IV) Complexes in the Presence of Ascorbate and Cysteine and within DLD-1 Cancer Cells

View Author Information
School of Chemistry, The University of Sydney, Sydney, New South Wales, 2006, Australia
Australian Synchrotron, Clayton, Victoria, 3168, Australia
§ Institute of Materials Structure Science, KEK, Tsukuba, Ibaraki 305-0801, Japan
*E-mail: [email protected]. Phone: +61-2-9351-3320. Fax: +61-2-9351-3329.
Cite this: J. Med. Chem. 2013, 56, 21, 8757–8764
Publication Date (Web):October 10, 2013
Copyright © 2013 American Chemical Society

    Article Views





    Read OnlinePDF (538 KB)
    Supporting Info (1)»


    Abstract Image

    The rapid and premature reduction of platinum(IV) complexes in vivo is a significant impediment to these complexes being successfully employed as anticancer prodrugs. This study investigates the influence of the platinum(IV) coordination sphere on the ease of reduction of the platinum center in various biological contexts. In the presence of the biological reductants, ascorbate and cysteine, platinum(IV) complexes with dicarboxylato equatorial ligands were observed to exhibit lower reduction potentials and slower reduction rates than analogous platinum(IV) complexes with dichlorido equatorial ligands. Diaminetetracarboxylatoplatinum(IV) complexes exhibited unusually long half-lives in the presence of excess reductants; however, the complexes exhibited moderate potency in vitro, indicative of rapid reduction within the intracellular environment. By use of XANES spectroscopy, trans-[Pt(OAc)2(ox)(en)] and trans-[PtCl2(OAc)2(en)] were observed to be reduced at a similar rate within DLD-1 cancer cells. This large variability in kinetic inertness of diaminetetracarboxylatoplatinum(IV) complexes in different biological contexts has significant implications for the design of platinum(IV) prodrugs.

    Supporting Information

    Jump To

    Synthesis and characterization of complexes IV, VII, and VIII; reduction monitored by 1H NMR time course experiments and pseudo-first - fitting; normalized XANES spectra of reduction in DLD-1 cells for complexes III and V; calibration of platinum solid standards. This material is available free of charge via the Internet at

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:

    Cited By

    This article is cited by 78 publications.

    1. Hana Kostrhunova, Brondwyn S. McGhie, Lenka Markova, Olga Novakova, Jana Kasparkova, Janice R. Aldrich-Wright, Viktor Brabec. Platinum(IV) Derivatives of [Pt(1S,2S-diaminocyclohexane)(5,6-dimethyl-1,10-phenanthroline)] with Diclofenac Ligands in the Axial Positions: A New Class of Potent Multi-action Agents Exhibiting Selectivity to Cancer Cells. Journal of Medicinal Chemistry 2023, 66 (12) , 7894-7908.
    2. Olga O. Krasnovskaya, Roman A. Akasov, Daniil V. Spector, Kirill G. Pavlov, Anna A. Bubley, Vladimir A. Kuzmin, Alexey A. Kostyukov, Evgeny V. Khaydukov, Elena V. Lopatukhina, Alevtina S. Semkina, Kseniya Yu. Vlasova, Sergey A. Sypalov, Alexander S. Erofeev, Petr V. Gorelkin, Alexander N. Vaneev, Vita N. Nikitina, Dmitrii A. Skvortsov, Daria A. Ipatova, Dmitrii M. Mazur, Nikolay V. Zyk, Dmitry A. Sakharov, Alexander G. Majouga, Elena K. Beloglazkina. Photoinduced Reduction of Novel Dual-Action Riboplatin Pt(IV) Prodrug. ACS Applied Materials & Interfaces 2023, 15 (10) , 12882-12894.
    3. Jianbing Wu, Yihui Hu, Hui Ye, Sheng Zhang, Jie Zhu, Duorui Ji, Yihua Zhang, Ya Ding, Zhangjian Huang. One Stone Two Birds: Redox-Sensitive Colocalized Delivery of Cisplatin and Nitric Oxide through Cascade Reactions. JACS Au 2022, 2 (10) , 2339-2351.
    4. Daniil V. Spector, Alexander S. Erofeev, Petr V. Gorelkin, Alexander N. Vaneev, Roman A. Akasov, Nikolay V. Ul’yanovskiy, Vita N. Nikitina, Alevtina S. Semkina, Kseniya Yu Vlasova, Mikhail A. Soldatov, Alexander L. Trigub, Dmitry A. Skvortsov, Alexander V. Finko, Nikolay V. Zyk, Dmitry A. Sakharov, Alexander G. Majouga, Elena K. Beloglazkina, Olga O. Krasnovskaya. Electrochemical Detection of a Novel Pt(IV) Prodrug with the Metronidazole Axial Ligand in the Hypoxic Area. Inorganic Chemistry 2022, 61 (37) , 14705-14717.
    5. Stefano Scoditti, Gloria Mazzone, Nico Sanna, Emilia Sicilia. Computational Exploration of the Synergistic Anticancer Effect of a Multi-Action Ru(II)–Pt(IV) Conjugate. Inorganic Chemistry 2022, 61 (32) , 12903-12912.
    6. Daniil V. Spector, Kirill G. Pavlov, Roman A. Akasov, Alexander N. Vaneev, Alexander S. Erofeev, Petr V. Gorelkin, Vita N. Nikitina, Elena V. Lopatukhina, Alevtina S. Semkina, Kseniya Yu. Vlasova, Dmitrii A. Skvortsov, Vitaly A. Roznyatovsky, Nikolay V. Ul’yanovskiy, Ilya I. Pikovskoi, Sergey A. Sypalov, Anastasiia S. Garanina, Stepan S. Vodopyanov, Maxim A. Abakumov, Yulia L. Volodina, Alina A. Markova, Albina S. Petrova, Dmitrii M. Mazur, Dmitry A. Sakharov, Nikolay V. Zyk, Elena K. Beloglazkina, Alexander G. Majouga, Olga O. Krasnovskaya. Pt(IV) Prodrugs with Non-Steroidal Anti-inflammatory Drugs in the Axial Position. Journal of Medicinal Chemistry 2022, 65 (12) , 8227-8244.
    7. Chad Groer, Ti Zhang, Ruolin Lu, Shuang Cai, Derek Mull, Aric Huang, Melanie Forrest, Cory Berkland, Daniel Aires, Marcus Laird Forrest. Intratumoral Cancer Chemotherapy with a Carrier-Based Immunogenic Cell-Death Eliciting Platinum (IV) Agent. Molecular Pharmaceutics 2020, 17 (11) , 4334-4345.
    8. Leila Tabrizi, Kerry Thompson, Katarzyna Mnich, Chetan Chintha, Adrienne M. Gorman, Liam Morrison, Janna Luessing, Noel F. Lowndes, Peter Dockery, Afshin Samali, Andrea Erxleben. Novel Pt(IV) Prodrugs Displaying Antimitochondrial Effects. Molecular Pharmaceutics 2020, 17 (8) , 3009-3023.
    9. Suxing Jin, Yan Guo, Dongfan Song, Zhenzhu Zhu, Zhenqin Zhang, Yuewen Sun, Tao Yang, Zijian Guo, Xiaoyong Wang. Targeting Energy Metabolism by a Platinum(IV) Prodrug as an Alternative Pathway for Cancer Suppression. Inorganic Chemistry 2019, 58 (9) , 6507-6516.
    10. Jun Liang, Aviva Levina, Junteng Jia, Peter Kappen, Chris Glover, Bernt Johannessen, Peter A. Lay. Reactivity and Transformation of Antimetastatic and Cytotoxic Rhodium(III)–Dimethyl Sulfoxide Complexes in Biological Fluids: An XAS Speciation Study. Inorganic Chemistry 2019, 58 (8) , 4880-4893.
    11. Eslam Dabbish, Fortuna Ponte, Nino Russo, Emilia Sicilia. Antitumor Platinium(IV) Prodrugs: A Systematic Computational Exploration of Their Reduction Mechanism by l-Ascorbic Acid. Inorganic Chemistry 2019, 58 (6) , 3851-3860.
    12. Jian Zhao, Zichen Xu, Jing Lin, and Shaohua Gou . Exploring the Hydrolytic Behavior of the Platinum(IV) Complexes with Axial Acetato Ligands. Inorganic Chemistry 2017, 56 (16) , 9851-9859.
    13. Hristo P. Varbanov, Simone Göschl, Petra Heffeter, Sarah Theiner, Alexander Roller, Frank Jensen, Michael A. Jakupec, Walter Berger, Mathea Sophia Galanski, Bernhard K. Keppler. A Novel Class of Bis- and Tris-Chelate Diam(m)inebis(dicarboxylato)platinum(IV) Complexes as Potential Anticancer Prodrugs. Journal of Medicinal Chemistry 2014, 57 (15) , 6751-6764.
    14. Sara La Manna, Daniela Marasco. Insights into molecular mechanisms of metallodrugs using metallomic studies. Inorganica Chimica Acta 2024, 560 , 121816.
    15. Javier E. López‐Hernández, Nazia Nayeem, José P. Cerón‐Carrasco, Afruja Ahad, Aiman Hafeez, Ignacio E. León, Maria Contel. Platinum(IV)–Gold(I) Agents with Promising Anticancer Activity: Selected Studies in 2D and 3D Triple‐Negative Breast Cancer Models. Chemistry – A European Journal 2023, 29 (59)
    16. Daniil Victorovich Spector, Anna Anatolievna Bubley, Elena Kimovna Beloglazkina, Olga Olegovna Krasnovskaya. Platinum(IV)-based prodrugs as an alternative to Pt(II)-based drugs: synthesis and biological action. Russian Chemical Reviews 2023, 92 (10)
    17. Ameneh Arabi, Marcus O. Cogley, Daniel Fabrizio, Shadrach Stitz, William A. Howard, Kraig A. Wheeler. Anticancer activity of nonpolar Pt(CH3)2I2{bipy} is found to be superior among four similar organoplatinum(IV) complexes. Journal of Molecular Structure 2023, 1274 , 134551.
    18. Daniil Spector, Alexander Erofeev, Peter Gorelkin, Dmitry Skvortsov, Alexander Trigub, Alina Markova, Vita Nikitina, Nikolay Ul'yanovskiy, Alexander Shtil’, Alevtina Semkina, Ksenia Vlasova, Nikolay Zyk, Alexander Majouga, Elena Beloglazkina, Olga Krasnovskaya. Biotinylated Pt( iv ) prodrugs with elevated lipophilicity and cytotoxicity. Dalton Transactions 2023, 52 (4) , 866-871.
    19. Tao Yang, Shuren Zhang, Hao Yuan, Ying Wang, Linxiang Cai, Hanhua Chen, Xiaoyu Wang, Dongfan Song, Xiaohui Wang, Zijian Guo, Xiaoyong Wang. Platinum‐Based TREM2 Inhibitor Suppresses Tumors by Remodeling the Immunosuppressive Microenvironment. Angewandte Chemie 2023, 135 (2)
    20. Tao Yang, Shuren Zhang, Hao Yuan, Ying Wang, Linxiang Cai, Hanhua Chen, Xiaoyu Wang, Dongfan Song, Xiaohui Wang, Zijian Guo, Xiaoyong Wang. Platinum‐Based TREM2 Inhibitor Suppresses Tumors by Remodeling the Immunosuppressive Microenvironment. Angewandte Chemie International Edition 2023, 62 (2)
    21. K.M. Deo, J.R. Aldrich-Wright. Metal complexes as chemotherapeutic agents. 2023, 744-793.
    22. Bin-Bin Pan, Hui-Zhong Liu, Wei-Han Meng, Xun-Cheng Su. Pt( iv ) complex selectively oxidizes alpha-synuclein methionine as disclosed by NMR. Inorganic Chemistry Frontiers 2022, 10 (1) , 296-304.
    23. Daniil Spector, Kirill Pavlov, Elena Beloglazkina, Olga Krasnovskaya. Recent Advances in Light-Controlled Activation of Pt(IV) Prodrugs. International Journal of Molecular Sciences 2022, 23 (23) , 14511.
    24. Aleen Khoury, Jennette A. Sakoff, Jayne Gilbert, Shawan Karan, Christopher P. Gordon, Janice R. Aldrich-Wright. Potent Platinum(IV) Prodrugs That Incorporate a Biotin Moiety to Selectively Target Cancer Cells. Pharmaceutics 2022, 14 (12) , 2780.
    25. Hiroaki Echigo, Kenji Mishiro, Masayuki Munekane, Takeshi Fuchigami, Yoji Kitamura, Seigo Kinuya, Kazuma Ogawa. Development and evaluation of a theranostic probe with RGD peptide introduced platinum complex to enable tumor-specific accumulation. Bioorganic & Medicinal Chemistry 2022, 70 , 116919.
    26. Aleen Khoury, Jennette A. Sakoff, Jayne Gilbert, Kieran F. Scott, Shawan Karan, Christopher P. Gordon, Janice R. Aldrich-Wright. Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity. Pharmaceutics 2022, 14 (4) , 787.
    27. Aviva Levina, Debbie Crans, Peter Lay. Advantageous Reactivity of Unstable Metal Complexes: Potential Applications of Metal-Based Anticancer Drugs for Intratumoral Injections. Pharmaceutics 2022, 14 (4) , 790.
    28. Mauro Ravera, Elisabetta Gabano, Michael J. McGlinchey, Domenico Osella. Pt( iv ) antitumor prodrugs: dogmas, paradigms, and realities. Dalton Transactions 2022, 51 (6) , 2121-2134.
    29. Yehong Tan, Hanhua Chen, Jie Zhang, Linxiang Cai, Suxing Jin, Dongfan Song, Tao Yang, Zijian Guo, Xiaoyong Wang. Platinum(IV) complexes as inhibitors of CD47-SIRPα axis for chemoimmunotherapy of cancer. European Journal of Medicinal Chemistry 2022, 229 , 114047.
    30. Richard Browning, Nia Thomas, Laura K. Marsh, Louise R. Tear, Joshua Owen, Eleanor Stride, Nicola J. Farrer. Ultrasound‐Triggered Delivery of Iproplatin from Microbubble‐Conjugated Liposomes. ChemistryOpen 2021, 10 (12) , 1170-1176.
    31. Zoufeng Xu, Zhigang Wang, Zhiqin Deng, Guangyu Zhu. Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs. Coordination Chemistry Reviews 2021, 442 , 213991.
    32. Hakan Nazlı, Gülşah Gedik. In-vitro evaluation of dendrimeric formulation of oxaliplatin. Pharmaceutical Development and Technology 2021, 26 (7) , 750-764.
    33. Yuewen Sun, Enmao Yin, Yehong Tan, Tao Yang, Dongfan Song, Suxing Jin, Zijian Guo, Xiaoyong Wang. Immunogenicity and cytotoxicity of a platinum( iv ) complex derived from capsaicin. Dalton Transactions 2021, 50 (10) , 3516-3522.
    34. Catherine K J Chen, Xiao Gui, Peter Kappen, Anna K Renfrew, Trevor W Hambley. The effect of charge on the uptake and resistance to reduction of platinum( iv ) complexes in human serum and whole blood models. Metallomics 2020, 12 (10) , 1599-1615.
    35. D. Khattib, M. Ishan, S. Karmakar, H. Kostrhunova, V. Brabec, D. Gibson. Oxidation of cis ‐Diamminediacetato Pt II with Hydrogen Peroxide Can Give Rise to Two Isomeric Pt IV Products. Chemistry – A European Journal 2020, 26 (43) , 9475-9480.
    36. Chunyan Jia, Yanwei Cong, Shaoping Pu, Linxiang Cai, Yunshuang Zhong, Xinzhong Zhang, Xiali Liao, Yamin Li, Bo Yang, Chuanzhu Gao. Synthesis, characterization, and biological activity of new mixed ammine/amine platinum(IV) complexes. Applied Organometallic Chemistry 2020, 34 (8)
    37. Catherine K. J. Chen, Peter Kappen, Dan Gibson, Trevor W. Hambley. trans -Platinum( iv ) pro-drugs that exhibit unusual resistance to reduction by endogenous reductants and blood serum but are rapidly activated inside cells: 1 H NMR and XANES spectroscopy study. Dalton Transactions 2020, 49 (23) , 7722-7736.
    38. Davide Corinti, Maria Elisa Crestoni, Simonetta Fornarini, Eslam Dabbish, Emilia Sicilia, Elisabetta Gabano, Elena Perin, Domenico Osella. A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes. JBIC Journal of Biological Inorganic Chemistry 2020, 25 (4) , 655-670.
    39. Aleen Khoury, Krishant M. Deo, Janice R. Aldrich-Wright. Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action. Journal of Inorganic Biochemistry 2020, 207 , 111070.
    40. Ana M.F. Phillips, Armando J.L. Pombeiro. Transition Metal-Based Prodrugs for Anticancer Drug Delivery. Current Medicinal Chemistry 2020, 26 (41) , 7476-7519.
    41. Catherine K.J. Chen, Trevor W. Hambley. The impact of highly electron withdrawing carboxylato ligands on the stability and activity of platinum(IV) pro-drugs. Inorganica Chimica Acta 2019, 494 , 84-90.
    42. Carlos Sanchez-Cano, Diego Gianolio, Isolda Romero-Canelon, Remi Tucoulou, Peter J. Sadler. Nanofocused synchrotron X-ray absorption studies of the intracellular redox state of an organometallic complex in cancer cells. Chemical Communications 2019, 55 (49) , 7065-7068.
    43. Trevor W. Hambley. Transporter and protease mediated delivery of platinum complexes for precision oncology. JBIC Journal of Biological Inorganic Chemistry 2019, 24 (4) , 457-466.
    44. Selin Hizal, Michaela Hejl, Michael A. Jakupec, Mathea S. Galanski, Bernhard K. Keppler. Synthesis, characterization, lipophilicity and cytotoxic properties of novel bis(carboxylato)oxalatobis(1-propylamine)platinum(IV) complexes. Inorganica Chimica Acta 2019, 491 , 76-83.
    45. Mauro Ravera, Elisabetta Gabano, Michael J. McGlinchey, Domenico Osella. A view on multi-action Pt(IV) antitumor prodrugs. Inorganica Chimica Acta 2019, 492 , 32-47.
    46. Doris Höfer, Klaudia Cseh, Michaela Hejl, Alexander Roller, Michael A. Jakupec, Mathea S. Galanski, Bernhard K. Keppler. Synthesis, characterization, cytotoxic activity, and 19F NMR spectroscopic investigations of (OC-6-33)-diacetato(ethane-1,2-diamine)bis(3,3,3-trifluoropropanoato)platinum(IV) and its platinum(II) counterpart. Inorganica Chimica Acta 2019, 490 , 190-199.
    47. Haifeng Wang, Xiande Yang, Caili Zhao, Peng George Wang, Xin Wang. Glucose-conjugated platinum(IV) complexes as tumor-targeting agents: design, synthesis and biological evaluation. Bioorganic & Medicinal Chemistry 2019, 27 (8) , 1639-1645.
    48. Catherine K J Chen, Peter Kappen, Trevor W Hambley. The reduction of cis -platinum( iv ) complexes by ascorbate and in whole human blood models using 1H NMR and XANES spectroscopy. Metallomics 2019, 11 (3) , 686-695.
    49. E. Gabano, M. Ravera, E. Perin, I. Zanellato, B. Rangone, M. J. McGlinchey, D. Osella. Synthesis and characterization of cyclohexane-1 R ,2 R -diamine-based Pt( iv ) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines. Dalton Transactions 2019, 48 (2) , 435-445.
    50. Ting Meng, Qi-Pin Qin, Zhen-Rui Wang, Li-Ting Peng, Hua-Hong Zou, Zhen-Yuan Gan, Ming-Xiong Tan, Kai Wang, Fu-Pei Liang. Synthesis and biological evaluation of substituted 3-(2′-benzimidazolyl)coumarin platinum(II) complexes as new telomerase inhibitors. Journal of Inorganic Biochemistry 2018, 189 , 143-150.
    51. Fortuna Ponte, Nino Russo, Emilia Sicilia. Insights from Computations on the Mechanism of Reduction by Ascorbic Acid of Pt IV Prodrugs with Asplatin and Its Chlorido and Bromido Analogues as Model Systems. Chemistry – A European Journal 2018, 24 (38) , 9572-9580.
    52. Francesco Porcaro, Stéphane Roudeau, Asuncion Carmona, Richard Ortega. Advances in element speciation analysis of biomedical samples using synchrotron-based techniques. TrAC Trends in Analytical Chemistry 2018, 104 , 22-41.
    53. Sarah Theiner, Márkó Grabarics, Luis Galvez, Hristo P. Varbanov, Nadine S. Sommerfeld, Mathea S. Galanski, Bernhard K. Keppler, Gunda Koellensperger. The impact of whole human blood on the kinetic inertness of platinum( iv ) prodrugs – an HPLC-ICP-MS study. Dalton Transactions 2018, 47 (15) , 5252-5258.
    54. L. M. Frensemeier, J. Mayr, G. Koellensperger, B. K. Keppler, C. R. Kowol, U. Karst. Structure elucidation and quantification of the reduction products of anticancer Pt( iv ) prodrugs by electrochemistry/mass spectrometry (EC-MS). The Analyst 2018, 143 (9) , 1997-2001.
    55. Linkui Bai, Chuanzhu Gao, Qinghua Liu, Congtao Yu, Zhuxin Zhang, Linxiang Cai, Bo Yang, Yunxu Qian, Jian Yang, Xiali Liao. Research progress in modern structure of platinum complexes. European Journal of Medicinal Chemistry 2017, 140 , 349-382.
    56. Doris Höfer, Hristo P. Varbanov, Michaela Hejl, Michael A. Jakupec, Alexander Roller, Mathea S. Galanski, Bernhard K. Keppler. Impact of the equatorial coordination sphere on the rate of reduction, lipophilicity and cytotoxic activity of platinum(IV) complexes. Journal of Inorganic Biochemistry 2017, 174 , 119-129.
    57. . Responsive Metal Complexes. 2017, 217-244.
    58. Yuchuan Wang, Haibo Wang, Hongyan Li, Hongzhe Sun. Application of Metallomics and Metalloproteomics for Understanding the Molecular Mechanisms of Action of Metal-Based Drugs. 2017, 199-222.
    59. Zeinab Ejehi, Alireza Ariafard. A computational mechanistic investigation into the reduction of Pt( iv ) prodrugs with two axial chlorides by biological reductants. Chemical Communications 2017, 53 (8) , 1413-1416.
    60. Josef Mayr, Petra Heffeter, Diana Groza, Luis Galvez, Gunda Koellensperger, Alexander Roller, Beatrix Alte, Melanie Haider, Walter Berger, Christian R. Kowol, Bernhard K. Keppler. An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo. Chemical Science 2017, 8 (3) , 2241-2250.
    61. Anna Escolà, Margarita Crespo, Concepción López, Josefina Quirante, Anusha Jayaraman, Ibrahim H. Polat, Josefa Badía, Laura Baldomà, Marta Cascante. On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions. Bioorganic & Medicinal Chemistry 2016, 24 (22) , 5804-5815.
    62. Melani Sooriyaarachchi, Jürgen Gailer, Natalia V. Dolgova, Ingrid J. Pickering, Graham N. George. Chemical basis for the detoxification of cisplatin-derived hydrolysis products by sodium thiosulfate. Journal of Inorganic Biochemistry 2016, 162 , 96-101.
    63. Dina Tolan, Valentina Gandin, Liam Morrison, Ahmed El-Nahas, Cristina Marzano, Diego Montagner, Andrea Erxleben. Oxidative Stress Induced by Pt(IV) Pro-drugs Based on the Cisplatin Scaffold and Indole Carboxylic Acids in Axial Position. Scientific Reports 2016, 6 (1)
    64. Simone Göschl, Hristo P. Varbanov, Sarah Theiner, Michael A. Jakupec, Mathea S. Galanski, Bernhard K. Keppler. The role of the equatorial ligands for the redox behavior, mode of cellular accumulation and cytotoxicity of platinum(IV) prodrugs. Journal of Inorganic Biochemistry 2016, 160 , 264-274.
    65. Mirco Fanelli, Mauro Formica, Vieri Fusi, Luca Giorgi, Mauro Micheloni, Paola Paoli. New trends in platinum and palladium complexes as antineoplastic agents. Coordination Chemistry Reviews 2016, 310 , 41-79.
    66. Dan Gibson. Platinum( iv ) anticancer prodrugs – hypotheses and facts. Dalton Transactions 2016, 45 (33) , 12983-12991.
    67. Jingran Dong, Yanli Ren, Shuying Huo, Shigang Shen, Jianzhong Xu, Hongwu Tian, Tiesheng Shi. Reduction of ormaplatin and cis-diamminetetrachloroplatinum( iv ) by ascorbic acid and dominant thiols in human plasma: kinetic and mechanistic analyses. Dalton Transactions 2016, 45 (28) , 11326-11337.
    68. Doris Höfer, Hristo P. Varbanov, Anton Legin, Michael A. Jakupec, Alexander Roller, Mathea S. Galanski, Bernhard K. Keppler. Tetracarboxylatoplatinum(IV) complexes featuring monodentate leaving groups — A rational approach toward exploiting the platinum(IV) prodrug strategy. Journal of Inorganic Biochemistry 2015, 153 , 259-271.
    69. Jun Xiang Ong, Jian Yu Yap, Siew Qi Yap, Wee Han Ang. Structure–activity relationship studies on rhodamine B-based fluorogenic probes and their activation by anticancer platinum(II) compounds. Journal of Inorganic Biochemistry 2015, 153 , 272-278.
    70. Xiaopeng Han, Jin Sun, Yongjun Wang, Zhonggui He. Recent Advances in Platinum (IV) Complex‐Based Delivery Systems to Improve Platinum (II) Anticancer Therapy. Medicinal Research Reviews 2015, 35 (6) , 1268-1299.
    71. Mauro Ravera, Elena Perin, Elisabetta Gabano, Ilaria Zanellato, Guido Panzarasa, Katia Sparnacci, Michele Laus, Domenico Osella. Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs. Journal of Inorganic Biochemistry 2015, 151 , 132-142.
    72. Mauro Ravera, Elisabetta Gabano, Ilaria Zanellato, Ilaria Bonarrigo, Manuela Alessio, Fabio Arnesano, Angela Galliani, Giovanni Natile, Domenico Osella. Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs. Journal of Inorganic Biochemistry 2015, 150 , 1-8.
    73. Verena Pichler, Simone Göschl, Ekaterina Schreiber-Brynzak, Michael A Jakupec, Mathea S Galanski, Bernhard K Keppler. Influence of reducing agents on the cytotoxic activity of platinum( iv ) complexes: induction of G2/M arrest, apoptosis and oxidative stress in A2780 and cisplatin resistant A2780cis cell lines. Metallomics 2015, 7 (7) , 1078-1090.
    74. Song Ding, Ulrich Bierbach. Target-selective delivery and activation of platinum-based anticancer agents. Future Medicinal Chemistry 2015, 7 (7) , 911-927.
    75. Yuchuan Wang, Haibo Wang, Hongyan Li, Hongzhe Sun. Metallomic and metalloproteomic strategies in elucidating the molecular mechanisms of metallodrugs. Dalton Transactions 2015, 44 (2) , 437-447.
    76. Valentina Gandin, Cristina Marzano, Giorgio Pelosi, Mauro Ravera, Elisabetta Gabano, Domenico Osella. trans , cis , cis ‐Bis(benzoato)dichlorido(cyclohexane‐1 R ,2 R ‐diamine)platinum(IV): a Prodrug Candidate for the Treatment of Oxaliplatin‐Refractory Colorectal Cancer. ChemMedChem 2014, 9 (6) , 1299-1305.
    77. Alice V. Klein, Trevor W. Hambley. Platinum‐Based Anticancer Agents. 2014, 9-45.
    78. Anna K. Renfrew. Transition metal complexes with bioactive ligands: mechanisms for selective ligand release and applications for drug delivery. Metallomics 2014, 6 (8) , 1324-1335.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    Pair your accounts.

    Export articles to Mendeley

    Get article recommendations from ACS based on references in your Mendeley library.

    You’ve supercharged your research process with ACS and Mendeley!

    STEP 1:
    Click to create an ACS ID

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

    Your Mendeley pairing has expired. Please reconnect